Dynamic change of lymphocytes associated with short-term prognosis in anti-MDA5-positive dermatomyositis with interstitial lung disease: a multicenter retrospective study

Clin Rheumatol. 2024 Nov;43(11):3399-3408. doi: 10.1007/s10067-024-07110-3. Epub 2024 Sep 18.

Abstract

Lymphopenia is a unique manifestation of anti-MDA5 positive dermatomyositis with interstitial lung disease (MDA5 + DM-ILD). This study aimed to investigate the relationship between dynamic changes in peripheral lymphocytes and short-term prognosis in patients of MDA5 + DM-ILD. Two hundred sixty-three MDA5 + DM-ILD patients were divided into different groups according to lymphocyte count and death or survival within 1 month, then the differences in clinical features and outcomes were compared. Associations between lymphocytes and risk of death within 1 month were also investigated in different lymphocyte groups using Cox proportional hazard models. A generalized additive mixed model (GAMM) was established to analyze the dynamic changes of lymphocytes in the death 1-month group. Lymphocytes of the patients who died within 1 month were significantly lower than survivors by different lymphocyte grouping methods, and the total lymphocytes showed a gradually decreasing trend in non-survivors. And the difference between survivors and non-survivors was more obvious over time. The lowest tertile of baseline lymphocytes as a reference, the hazard ratios for death within 1 month in the highest tertile were 0.497 (95% CI 0.26-0.949, P for trend = 0.033) after adjustment for potential confounders. GAMM analysis found a mean daily decrease of lymphocytes (0.034 × 10^9/L) after admission in death 1-month patients. Low baseline lymphocytes and gradually declined lymphocytes are both associated with a high risk of death within 1 month. However dynamic changes in lymphocytes can better reflect the disease status and better predict the short-term prognosis than baseline lymphocytes in MDA5 + DM-ILD patients. Key points •Low baseline lymphocytes and gradually decreased trend along time correlated with poor short-term prognosis in MDA5 + DM-ILD patients. •Dynamic changes of lymphocytes can better reflect the disease status and better predict the 1-month prognosis than baseline lymphocytes in MDA5 + DM-ILD patients. •Generalized additive mixed model (GAMM) analysis found that in 1-month non-survivors, peripheral blood lymphocytes decreased by 0.034 × 10^9/L per day, while the lymphocytes in survivors gradually increased.

Keywords: Dermatomyositis; Interstitial lung disease; MDA5; Peripheral lymphocyte count.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Autoantibodies / blood
  • Dermatomyositis* / blood
  • Dermatomyositis* / complications
  • Dermatomyositis* / immunology
  • Female
  • Humans
  • Interferon-Induced Helicase, IFIH1* / immunology
  • Lung Diseases, Interstitial* / blood
  • Lung Diseases, Interstitial* / complications
  • Lung Diseases, Interstitial* / immunology
  • Lung Diseases, Interstitial* / mortality
  • Lymphocyte Count
  • Lymphocytes*
  • Lymphopenia / blood
  • Lymphopenia / complications
  • Lymphopenia / immunology
  • Male
  • Middle Aged
  • Prognosis
  • Proportional Hazards Models
  • Retrospective Studies

Substances

  • Interferon-Induced Helicase, IFIH1
  • IFIH1 protein, human
  • Autoantibodies